Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Meningococcal Vaccines in these regions, from 2012 to 2022 (forecast).
United States Meningococcal Vaccines market competition by top manufacturers/players, with Meningococcal Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Menactra
Menomune
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Meningococcal Vaccines Market Report 2017
1 Meningococcal Vaccines Overview
1.1 Product Overview and Scope of Meningococcal Vaccines
1.2 Classification of Meningococcal Vaccines by Product Category
1.2.1 United States Meningococcal Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Meningococcal Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Menactra
1.2.4 Menomune
1.3 United States Meningococcal Vaccines Market by Application/End Users
1.3.1 United States Meningococcal Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 United States Meningococcal Vaccines Market by Region
1.4.1 United States Meningococcal Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Meningococcal Vaccines Status and Prospect (2012-2022)
1.4.3 Southwest Meningococcal Vaccines Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Meningococcal Vaccines Status and Prospect (2012-2022)
1.4.5 New England Meningococcal Vaccines Status and Prospect (2012-2022)
1.4.6 The South Meningococcal Vaccines Status and Prospect (2012-2022)
1.4.7 The Midwest Meningococcal Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Meningococcal Vaccines (2012-2022)
1.5.1 United States Meningococcal Vaccines Sales and Growth Rate (2012-2022)
1.5.2 United States Meningococcal Vaccines Revenue and Growth Rate (2012-2022)
2 United States Meningococcal Vaccines Market Competition by Players/Suppliers
2.1 United States Meningococcal Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Meningococcal Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Meningococcal Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Meningococcal Vaccines Market Competitive Situation and Trends
2.4.1 United States Meningococcal Vaccines Market Concentration Rate
2.4.2 United States Meningococcal Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Meningococcal Vaccines Manufacturing Base Distribution, Sales Area, Product Type
3 United States Meningococcal Vaccines Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Meningococcal Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Meningococcal Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Meningococcal Vaccines Price by Region (2012-2017)
4 United States Meningococcal Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Meningococcal Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Meningococcal Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Meningococcal Vaccines Price by Type (2012-2017)
4.4 United States Meningococcal Vaccines Sales Growth Rate by Type (2012-2017)
5 United States Meningococcal Vaccines Sales (Volume) by Application (2012-2017)
5.1 United States Meningococcal Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Meningococcal Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Meningococcal Vaccines Players/Suppliers Profiles and Sales Data
6.1 GlaxoSmithKline
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Meningococcal Vaccines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 JN-International Medical
6.2.2 Meningococcal Vaccines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 JN-International Medical Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Novartis International
6.3.2 Meningococcal Vaccines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novartis International Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi
6.4.2 Meningococcal Vaccines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.2 Meningococcal Vaccines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Baxter International
6.6.2 Meningococcal Vaccines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Baxter International Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
…
7 Meningococcal Vaccines Manufacturing Cost Analysis
7.1 Meningococcal Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Meningococcal Vaccines
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Meningococcal Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Meningococcal Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Meningococcal Vaccines Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Meningococcal Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Meningococcal Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Meningococcal Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Meningococcal Vaccines Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
About Us
Global QYResearch (http://globalqyresearch.com/) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.
Contact Us:
Unit 1, 26 Cleveland Road, South Woodford, London,
E182AN, United Kingdom
Call: +44 20 3239 2407
Comments
Post a Comment